It has not been evaluated for safety, dosing, efficacy, or long-term effects in people, and it is not registered as an investigational drug for such use
Based on your results, we create a tailored regenerative plancombining therapies like PRP, exosomes, peptides, ozone, and targeted rehabilitation
10.1186/s12893-022-01727-4 49
In some embodiments, the otic formulation or composition comprises between about 0.001% to about 15% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof
[] Under the influence of internal and external factors, advanced glycation end products produced in the ovarian microenvironment downregulate nicotinamide adenine dinucleotide phosphate and mitogen-activated protein kinase (MAPK) expression